Taken together, the disparity between active and immunodetectable chemerin warrants that caution should be taken when interpreting data from traditional chemerin ELISAs or western blots as they may not accurately predict active chemerin concentrations especially in situations where an inflammatory response is present, which includes obesity. The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.